Clinical Trial, Phase I

The effect of IgVH mutational status on the induction of apoptosis by rituximab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: evidence from a clinical phase I/II trial

Vol. 91 No. 9 (2006): September, 2006